Selection and Characterization of a Candidate Therapeutic Bacteriophage That Lyses the Escherichia coli O104:H4 Strain from the 2011 Outbreak in Germany

Maia Merabishvili, Daniel de Vos, Gilbert Verbeken, Andrew M. Kropinski, Dieter Vandenheuvel, Rob Lavigne, Pierre Wattiau, Jan Mast, Catherine Ragimbeau, Joel Mossong, Jacques Scheres, Nina Chanishvili, Mario Vaneechoutte, Jean Paul Pirnay

Résultats de recherche: Contribution à un journalArticleRevue par des pairs

Résumé

In 2011, a novel strain of O104:H4 Escherichia coli caused a serious outbreak of foodborne hemolytic uremic syndrome and bloody diarrhea in Germany. Antibiotics were of questionable use and 54 deaths occurred. Candidate therapeutic bacteriophages that efficiently lyse the E. coli O104:H4 outbreak strain could be selected rather easily from a phage bank or isolated from the environment. It is argued that phage therapy should be more considered as a potential armament against the growing threat of (resistant) bacterial infections.

langue originaleAnglais
Numéro d'articlee52709
journalPLoS ONE
Volume7
Numéro de publication12
Les DOIs
étatPublié - 21 déc. 2012

Empreinte digitale

Examiner les sujets de recherche de « Selection and Characterization of a Candidate Therapeutic Bacteriophage That Lyses the Escherichia coli O104:H4 Strain from the 2011 Outbreak in Germany ». Ensemble, ils forment une empreinte digitale unique.

Contient cette citation